Skip to content

Author

L. Holland

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access 2026

The impact of axillary lymph node dissection on the indication of adjuvant abemaciclib in high-risk hormone receptor-positive breast cancer: real-world analysis from a multicenter cohort in Brazil

Introduction: Adjuvant abemaciclib combined with endocrine therapy improves outcomes in patients with high-risk, hormone receptor-positive (HR+)/human epidermal growth factor receptor 2 (HER2)-negative early breast cancer. Lymph node involvement is a key determinant of recurrence risk and treatment decisions. However,...

L. Holland, L. Testa, C. Cavalcanti et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.